{"key":"op_284_KR","page":{"url":"https://ru.bookimed.com/clinics/country=republic-of-korea/procedure=targetnaya-terapiya/","procedure":{"id":284,"slug":"targetnaya-terapiya","name":"Таргетная терапия","name_forms":{"plural":{"status":"missing","reason":"not_collected"},"genitive":{"status":"missing","reason":"not_collected"}},"type":"therapy","grammar_number":{"status":"missing","reason":"not_collected"},"parent_id":"oncology","family_attribute":{"status":"missing","reason":"not_collected"}},"country":{"id":36,"iso":"KR","name":"Южная Корея"},"currency":"USD","data_date":"2026-10-02"},"pages":{"clinics_url":"https://ru.bookimed.com/clinics/country=republic-of-korea/procedure=targetnaya-terapiya/","cost_url":"https://ru.bookimed.com/clinics/country=republic-of-korea/procedure=targetnaya-terapiya/cost/","best_url":{"status":"missing","reason":"template not live"}},"price":{"from":6500,"to":12500,"avg":{"status":"missing","reason":"no_offers"},"us":{"from":9000,"to":20000},"uk":{"from":3800,"to":9500},"by_technique":[{"technique":"Small-molecule inhibitors (oral, e.g. tyrosine kinase inhibitors)","technique_id":"small-molecule-inhibitors","price_from":6500,"currency":"USD","source":"estimate","date":"2026-11-17"},{"technique":"Monoclonal antibodies (intravenous or subcutaneous)","technique_id":"monoclonal-antibodies","price_from":8000,"currency":"USD","source":"estimate","date":"2026-11-17"},{"technique":"Antibody-drug conjugates","technique_id":"antibody-drug-conjugates","price_from":11000,"currency":"USD","source":"estimate","date":"2026-11-17"}],"by_city":[{"city":"Инчхон","from":3800},{"city":"Сеул","from":3800}],"per_unit":{"status":"missing","reason":"not_collected"},"factors":{"status":"missing","reason":"not_collected"},"tiers":{"status":"missing","reason":"no_offers"},"comparison":[{"country_iso":"UA","from":1800,"to":4800},{"country_iso":"FR","from":6500,"to":13000},{"country_iso":"GB","from":3800,"to":9500},{"country_iso":"US","from":9000,"to":20000},{"country_iso":"IL","from":6500,"to":12500},{"country_iso":"TR","from":3000,"to":6000},{"country_iso":"MX","from":3500,"to":8000},{"country_iso":"DE","from":3000,"to":13500},{"country_iso":"CA","from":9000,"to":24000},{"country_iso":"AE","from":6500,"to":14000},{"country_iso":"TH","from":1000,"to":9000},{"country_iso":"PL","from":2500,"to":6000},{"country_iso":"CZ","from":3500,"to":8000},{"country_iso":"AT","from":9000,"to":21000},{"country_iso":"ES","from":13500,"to":{"status":"missing","reason":"not_collected"}},{"country_iso":"IT","from":4500,"to":9000},{"country_iso":"CN","from":3500,"to":11000},{"country_iso":"AU","from":9000,"to":21000},{"country_iso":"IN","from":1000,"to":8500},{"country_iso":"MY","from":6500,"to":13500},{"country_iso":"VN","from":4500,"to":9500},{"country_iso":"BR","from":4500,"to":7000},{"country_iso":"EG","from":1000,"to":4800}],"base_country":"US","base_is_fallback":false},"savings":{"pct":28,"variant":"ranges_overlap"},"package":{"included":{"status":"missing","reason":"no_offers"},"excluded":{"status":"missing","reason":"no_offers"},"extra_charges":{"status":"missing","reason":"not_collected"}},"clinics":{"count":8,"items":[{"id":262,"name":"Samsung Medical Center","city":"Seoul","rating":4.5,"reviews_count":25,"accreditations":["International Organization for Standardization","Korean Institute for Healthcare Accreditation","World's Best Hospitals 2021 by Newsweek","World's Best Smart Hospitals 2021 by Newsweek","World's Best Hospitals 2022 by Newsweek","World's Best Smart Hospitals 2023 by Newsweek"],"rank":1,"has_procedure":true,"why_ranked":"Asia's largest cancer center with 17 disease-specific departments. Conducts clinical trials offering access to the latest targeted therapy protocols, backed by over 50,000 patients treated.","bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":8459,"name":"Myongji Hospital","city":"Goyang","rating":3.6,"reviews_count":{"status":"missing","reason":"not_collected"},"accreditations":["Advanced Regenerative Medicine Implementation Institution (Ministry of Health and Welfare, Republic of Korea)"],"rank":2,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":226,"name":"Ewha Womans University Medical Center","city":"Seoul","rating":5,"reviews_count":9,"accreditations":["Joint Commission International","Korean Institute for Healthcare Accreditation","World's Best Hospitals 2021 by Newsweek","World's Best Hospitals 2022 by Newsweek"],"rank":3,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":229,"name":"Gachon University Gil Medical Center","city":"Incheon","rating":4.8,"reviews_count":5,"accreditations":["World's Best Hospitals 2021 by Newsweek"],"rank":4,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":408,"name":"Seoul National University Bundang Hospital (SNUBH)","city":"Seoul","rating":4.9,"reviews_count":7,"accreditations":["Global Healthcare Accreditation Program","World's Best Hospitals 2021 by Newsweek","World's Best Smart Hospitals 2023 by Newsweek"],"rank":5,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":254,"name":"Severance Hospital","city":"Seoul","rating":4.5,"reviews_count":43,"accreditations":["Joint Commission International","Korean Institute for Healthcare Accreditation","World's Best Hospitals 2021 by Newsweek","World's Best Smart Hospitals 2021 by Newsweek","World's Best Hospitals 2022 by Newsweek","World's Best Smart Hospitals 2023 by Newsweek"],"rank":6,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":421,"name":"Seoul National University Hospital (SNUH)","city":"Seoul","rating":5,"reviews_count":1,"accreditations":["World's Best Hospitals 2021 by Newsweek","World's Best Smart Hospitals 2021 by Newsweek","World's Best Hospitals 2022 by Newsweek","World's Best Smart Hospitals 2023 by Newsweek"],"rank":7,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":462,"name":"Korea University Anam Hospital","city":"Seoul","rating":{"status":"missing","reason":"not_collected"},"reviews_count":{"status":"missing","reason":"not_collected"},"accreditations":["Joint Commission International","Korean Institute for Healthcare Accreditation","World's Best Hospitals 2021 by Newsweek","World's Best Smart Hospitals 2021 by Newsweek","World's Best Hospitals 2022 by Newsweek","World's Best Smart Hospitals 2023 by Newsweek"],"rank":8,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}}]},"doctors":{"count":1,"languages":{"status":"missing","reason":"not_collected"}},"cities":[{"id":327,"slug":"inchhon","name":"Инчхон","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":3800,"profile":{"city_type":"City in northwestern Republic of Korea","access":["Incheon Airport (ICN), 48 km west of Seoul"],"sources":["https://en.wikipedia.org/wiki/Incheon","https://en.wikipedia.org/wiki/Incheon_International_Airport"],"checked_at":"2026-11-03","status":"ok"}},{"id":328,"slug":"seul","name":"Сеул","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":3800,"profile":{"city_type":"Capital of Republic of Korea","access":["Incheon Airport (ICN), 48 km west of Seoul","Gimpo Airport (GMP), 15 km west of central Seoul"],"sources":["https://en.wikipedia.org/wiki/Seoul","https://en.wikipedia.org/wiki/Incheon_International_Airport","https://en.wikipedia.org/wiki/Gimpo_International_Airport"],"checked_at":"2026-11-03","status":"ok"}}],"offers":{"active":{"status":"missing","reason":"no_offers"},"active_with_related":{"status":"missing","reason":"no_offers"},"hospital_nights_median":{"status":"missing","reason":"no_offers"},"days_in_country_median":{"status":"missing","reason":"no_offers"},"top_offers":{"status":"missing","reason":"no_offers"},"packages":{"status":"missing","reason":"no_offers"},"related_packages":{"status":"missing","reason":"no_offers"},"other_packages":{"status":"missing","reason":"no_offers"}},"medical":{"indications":["Cancers with molecular targets: HER2, EGFR, ALK, BRAF, BCR-ABL","Hematologic malignancies and solid tumors with a matched targeted agent","Some non-cancer conditions with defined molecular targets"],"contraindications":["Known severe hypersensitivity to the specific agent or its components","Pregnancy and breastfeeding for many agents (agent-specific)","Severe uncontrolled liver, heart or lung dysfunction (relative, agent-dependent)","Clinically significant drug interactions with the specific agent (relative, agent-specific)"],"operation_hours":{"min":0.5,"max":3,"unit":"hours","qualifier":"Per infusion visit; first infusion is longest. Oral agents are taken at home."},"anesthesia":["none"],"sessions_or_stages":{"sessions":{"min":4,"max":13,"unit":"visits","qualifier":"Infusion-based schedule every 1-3 weeks until first imaging; oral agents need no infusion visits."},"stages":[{"code":"biomarker_confirmation","label":"Biomarker confirmation and baseline tests","after":{"min":0,"max":0,"unit":"days","qualifier":"Before first dose."}},{"code":"treatment_start","label":"First dose or infusion","after":{"min":0,"max":7,"unit":"days","qualifier":"Starts once testing is confirmed."}},{"code":"response_assessment","label":"First response imaging","after":{"min":56,"max":90,"unit":"days","qualifier":"After several cycles."}}],"qualifier":"Treatment continues until progression or intolerance; typical first-phase schedule shown."},"hospital_nights":{"value":{"min":0,"max":0,"unit":"nights","qualifier":"Typical oral or infusion-based cycles are given without overnight stay; inpatient stay is not usual for uncomplicated treatment."},"source":"parsed_details"},"treatment_conditions":["outpatient"],"rehabilitation_days":{"min":0,"max":3,"unit":"days","qualifier":"Ordinary activity resumes quickly; longer if infusion reactions or fatigue occur."},"fly_home_after_days":{"min":1,"max":3,"unit":"days","qualifier":"After first dose, oncology team usually wants early tolerance observed; depends on agent and infusion reactions."},"back_to_work_days":{"min":0,"max":3,"unit":"days","qualifier":"Most patients keep working; depends on agent side effects and infusion schedule."},"exercise_resume_weeks":{"min":0,"max":1,"unit":"weeks","qualifier":"Light activity usually continues; intensity limited by fatigue, rash, diarrhea or cardiac precautions."},"final_result_months":{"min":2,"max":6,"unit":"months","qualifier":"Response is judged by imaging after several cycles; depends on tumor type and agent."},"result_longevity":"Response lasts as long as the drug is effective, often months to several years. Acquired resistance eventually develops in many cancers.","main_risks":["Skin reactions such as rash and dryness","Diarrhea, nausea and other gastrointestinal effects","Liver enzyme elevation","Hypertension, cardiac effects or bleeding with certain agents","Infusion reactions with antibody-based agents","Blood count changes"],"complication_rate_pct":{"min":20,"max":50,"unit":"percent","qualifier":"Grade 3-4 adverse events during treatment; any-grade side effects are far more common, varying by agent."},"revision_rate_pct":{"status":"missing","reason":"not_collected"},"success":{"metric":"Objective tumor response rate at first imaging","value":60,"horizon":"2-3 months","source":{"status":"missing","reason":"not_collected"},"evidence_status":"limited"},"scars":"No incisions or scars; only minor puncture marks from IV cannulation.","pain":"Treatment itself is painless apart from IV cannulation. Side effects such as rash, mouth sores or joint aches are usually mild to moderate.","preparation":["Molecular target or biomarker confirmed by tissue or blood testing","Baseline blood tests and organ function assessment","Review of current medications and supplements with the oncology team","Baseline cardiac or other agent-specific assessment where required","Discussion of expected side effects and contraception where relevant"],"recovery_timeline":[{"phase":"Treatment day","description":"Oral dose started or infusion given with observation for reactions.","restrictions":["Report fever or breathing difficulty immediately","Follow agent-specific food and drug rules"]},{"phase":"First 2 weeks","description":"Early side effects such as rash, diarrhea or fatigue may appear and are managed with supportive care.","restrictions":["Avoid sun exposure","Avoid new supplements without approval"]},{"phase":"Ongoing cycles","description":"Treatment continues with periodic blood tests and imaging to assess response.","restrictions":["Contraception where relevant","Avoid grapefruit with some agents"]}],"follow_up_visits":[{"purpose":"assessment","requirement":"routine","after":{"min":7,"max":21,"unit":"days","qualifier":"Early tolerance check with blood tests and side-effect review."}},{"purpose":"result_review","requirement":"routine","after":{"min":56,"max":90,"unit":"days","qualifier":"First response imaging and blood markers; timing depends on agent and cancer type."}}],"sources":{"status":"missing","reason":"not_collected"},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Check that your tumor has been tested for the drug's target. Why: the drug is chosen for a specific target found in the tumor","scope":"procedure","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies/targeted-therapies-fact-sheet","host":"cancer.gov","quote":"Most of the time, your tumor will need to be tested to see if it contains targets for which there is a drug.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"C2","text":"Check the qualifications of the medical team that will treat you","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Have you checked the qualifications of the medical team treating you?","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"C3","text":"Make sure you are clear how your aftercare will be coordinated after treatment abroad","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Ensure you're clear about how your aftercare will be coordinated.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"C4","text":"Check that the surgeon who consults with you is the same person who will carry out the procedure","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Check that the surgeon you consult with, will be the same person carrying out the procedure.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C5","text":"Expect two consultations with the treating surgeon before any surgery, which also gives you time to reconsider","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/conditions/cosmetic-procedures/cosmetic-surgery-abroad/","host":"nhs.uk","quote":"You should have 2 consultations with the surgeon treating you before any surgery.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"Pressure to decide quickly, or cheap time-limited offers to book now","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Don’t be pressured into quick decisions either through forceful persuasion or cheap, time limited offers.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"F2","text":"The doctor you consult may not be the one who actually treats you","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Check that the surgeon you consult with, will be the same person carrying out the procedure.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"F3","text":"Adverts or information promising complete success for the treatment","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Any advert or information that guarantees complete success should raise concerns.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"warning_signs":{"status":"ok","items":[{"id":"W1","text":"Unusual bleeding or bruising during targeted therapy","urgency":"contact_clinic","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/side-effects/bleeding-bruising","host":"cancer.gov","quote":"Some cancer treatments, such as chemotherapy and targeted therapy, can increase your risk of bleeding and bruising.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W2","text":"Diarrhea that lasts or becomes more severe","urgency":"contact_clinic","general":false,"source":{"url":"https://cancer.gov/about-cancer/treatment/side-effects/diarrhea","host":"cancer.gov","quote":"Ask the health care team about when you should call them if the diarrhea lasts or becomes more severe.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W3","text":"Fever higher than your care team expects","urgency":"contact_clinic","general":true,"source":{"url":"https://mdanderson.org/patients-family/diagnosis-treatment/emotional-physical-effects/targeted-therapy-side-effects.html","host":"mdanderson.org","quote":"A fever higher than what your care team told you to expect","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"take_home":{"status":"ok","items":[{"id":"T1","text":"Shows which follow-up tests are due and which doctors are responsible for care","document":"written aftercare plan","source":{"url":"https://www.cdc.gov/cancer/survivors/life-after-cancer/survivorship-care-plans.htm","host":"cdc.gov","quote":"Your plan should say when you need to get follow-up tests, and which doctors are responsible for your care.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":403}},{"id":"T2","text":"Gives the home doctor an up-to-date, clear picture of the treatment received","document":"end of treatment summary","source":{"url":"https://cht.nhs.uk/services/clinical-services/oncology/end-of-treatment-summary","host":"cht.nhs.uk","quote":"It also provides the GP with an up-to-date and clear understanding of the patient's treatment.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"T3","text":"Ask for copies of all prescriptions before you leave","document":"prescription copies","source":{"url":"https://travelhealthpro.org.uk/news/699/travelling-abroad-for-treatment","host":"travelhealthpro.org.uk","quote":"Remember to ask for copies of all your treatment records, including prescriptions, scans and x-rays before you leave.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"preop_tests":{"status":"ok","items":[{"id":"T1","name":"Blood tests","aliases":["Blood tests","Blood test","Blood test results","Blood testing"],"kind":"lab","origin":[{"field":"preparation","text":"Molecular target or biomarker confirmed by tissue or blood testing"},{"field":"preparation","text":"Baseline blood tests and organ function assessment"},{"field":"initial_assessment_documents","text":"Recent blood test results"},{"field":"packages","text":"Blood tests"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T2","name":"Genomic testing","aliases":["Genomic testing","Molecular or genomic testing","Molecular testing"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"Molecular or genomic testing report"}],"what_it_checks":{"text":"Helps doctors tailor the targeted treatment to the individual patient","source":{"url":"https://www.ncbi.nlm.nih.gov/sites/books/n/nap21860/ch1/","host":"ncbi.nlm.nih.gov","quote":"Such predictive biomarker tests are used by health care providers to tailor treatment to an individual patient's clinical condition and treatment goals.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T3","name":"CT scan","aliases":["CT scan","CT","CT scans","Computed tomography"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Recent CT or PET-CT scans"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T4","name":"PET-CT scan","aliases":["PET-CT scan","PET-CT","PET-CT scans","PET CT"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Recent CT or PET-CT scans"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T5","name":"Blood biochemistry test","aliases":["Blood biochemistry test","Biochemistry blood test"],"kind":"lab","origin":[{"field":"packages","text":"Biochemistry blood test"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null}],"checked_at":"2026-11-16","next_check_at":"2027-11-16","version":1},"prep_in_advance":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-16","next_check_at":"2027-02-14"},"visit_and_day":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-16","next_check_at":"2027-02-14"},"if_something_changes":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-16","next_check_at":"2027-02-14"}},"parsed_details":{"procedure_type":"therapy","fields":{"anesthesia":["none"],"back_to_work_days":{"min":0,"max":3,"unit":"days","qualifier":"Most patients keep working; depends on agent side effects and infusion schedule."},"complication_rate_pct":{"min":20,"max":50,"unit":"percent","qualifier":"Grade 3-4 adverse events during treatment; any-grade side effects are far more common, varying by agent."},"contraindications":["Known severe hypersensitivity to the specific agent or its components","Pregnancy and breastfeeding for many agents (agent-specific)","Severe uncontrolled liver, heart or lung dysfunction (relative, agent-dependent)","Clinically significant drug interactions with the specific agent (relative, agent-specific)"],"days_in_clinic":{"min":0,"max":0,"unit":"nights","qualifier":"Typical oral or infusion-based cycles are given without overnight stay; inpatient stay is not usual for uncomplicated treatment."},"diagnostic_duration_minutes":null,"diagnostic_preparation":null,"diagnostic_referral_needed":null,"diagnostic_result_time_hours":null,"exercise_resume_weeks":{"min":0,"max":1,"unit":"weeks","qualifier":"Light activity usually continues; intensity limited by fatigue, rash, diarrhea or cardiac precautions."},"final_result_months":{"min":2,"max":6,"unit":"months","qualifier":"Response is judged by imaging after several cycles; depends on tumor type and agent."},"fly_home_after_days":{"min":1,"max":3,"unit":"days","qualifier":"After first dose, oncology team usually wants early tolerance observed; depends on agent and infusion reactions."},"follow_up_visits":[{"purpose":"assessment","after":{"min":7,"max":21,"unit":"days","qualifier":"Early tolerance check with blood tests and side-effect review."},"requirement":"routine"},{"purpose":"result_review","after":{"min":56,"max":90,"unit":"days","qualifier":"First response imaging and blood markers; timing depends on agent and cancer type."},"requirement":"routine"}],"indications":["Cancers with molecular targets: HER2, EGFR, ALK, BRAF, BCR-ABL","Hematologic malignancies and solid tumors with a matched targeted agent","Some non-cancer conditions with defined molecular targets"],"main_risks":["Skin reactions such as rash and dryness","Diarrhea, nausea and other gastrointestinal effects","Liver enzyme elevation","Hypertension, cardiac effects or bleeding with certain agents","Infusion reactions with antibody-based agents","Blood count changes"],"pain":"Treatment itself is painless apart from IV cannulation. Side effects such as rash, mouth sores or joint aches are usually mild to moderate.","preparation":["Molecular target or biomarker confirmed by tissue or blood testing","Baseline blood tests and organ function assessment","Review of current medications and supplements with the oncology team","Baseline cardiac or other agent-specific assessment where required","Discussion of expected side effects and contraception where relevant"],"recovery_timeline":[{"phase":"Treatment day","description":"Oral dose started or infusion given with observation for reactions.","restrictions":["Report fever or breathing difficulty immediately","Follow agent-specific food and drug rules"]},{"phase":"First 2 weeks","description":"Early side effects such as rash, diarrhea or fatigue may appear and are managed with supportive care.","restrictions":["Avoid sun exposure","Avoid new supplements without approval"]},{"phase":"Ongoing cycles","description":"Treatment continues with periodic blood tests and imaging to assess response.","restrictions":["Contraception where relevant","Avoid grapefruit with some agents"]}],"rehabilitation_days":{"min":0,"max":3,"unit":"days","qualifier":"Ordinary activity resumes quickly; longer if infusion reactions or fatigue occur."},"result_longevity":"Response lasts as long as the drug is effective, often months to several years. Acquired resistance eventually develops in many cancers.","revision_rate_pct":null,"scars":"No incisions or scars; only minor puncture marks from IV cannulation.","sessions_or_stages":{"sessions":{"min":4,"max":13,"unit":"visits","qualifier":"Infusion-based schedule every 1-3 weeks until first imaging; oral agents need no infusion visits."},"stages":[{"code":"biomarker_confirmation","label":"Biomarker confirmation and baseline tests","after":{"min":0,"max":0,"unit":"days","qualifier":"Before first dose."}},{"code":"treatment_start","label":"First dose or infusion","after":{"min":0,"max":7,"unit":"days","qualifier":"Starts once testing is confirmed."}},{"code":"response_assessment","label":"First response imaging","after":{"min":56,"max":90,"unit":"days","qualifier":"After several cycles."}}],"qualifier":"Treatment continues until progression or intolerance; typical first-phase schedule shown."},"success":{"metric":"Objective tumor response rate at first imaging","value":60,"unit":"percent","horizon":"2-3 months","population":"Adults with biomarker-matched advanced cancer receiving a matched targeted agent","evidence_status":"limited"},"techniques":[{"name":"Small-molecule inhibitors (oral, e.g. tyrosine kinase inhibitors)","suits_whom":"Patients whose tumor carries a matching targetable alteration","recovery":"No recovery period; usually taken continuously at home with periodic monitoring."},{"name":"Monoclonal antibodies (intravenous or subcutaneous)","suits_whom":"Patients with target-expressing tumors such as HER2-positive cancers","recovery":"Given at scheduled infusion visits; usually no recovery time beyond infusion-related effects."},{"name":"Antibody-drug conjugates","suits_whom":"Selected patients with target-expressing cancers and suitable prior treatment history","recovery":"Given at scheduled infusion visits with monitoring for agent-specific toxicity."}],"treatment_conditions":["outpatient"],"treatment_duration_hours":{"min":0.5,"max":3,"unit":"hours","qualifier":"Per infusion visit; first infusion is longest. Oral agents are taken at home."},"initial_assessment_documents":["Pathology report with tumor type and stage","Molecular or genomic testing report","Recent CT or PET-CT scans","Summary of previous cancer treatments","Recent blood test results","Oncologist's latest treatment notes (if available)"],"travel_trips":{"min":2,"max":3,"one_trip_possible":false,"qualifier":"Start visit with first dose and tolerance check, then response imaging at 2-3 months; routine monitoring at home."},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Check that your tumor has been tested for the drug's target. Why: the drug is chosen for a specific target found in the tumor","scope":"procedure","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies/targeted-therapies-fact-sheet","host":"cancer.gov","quote":"Most of the time, your tumor will need to be tested to see if it contains targets for which there is a drug.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"C2","text":"Check the qualifications of the medical team that will treat you","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Have you checked the qualifications of the medical team treating you?","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"C3","text":"Make sure you are clear how your aftercare will be coordinated after treatment abroad","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Ensure you're clear about how your aftercare will be coordinated.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"C4","text":"Check that the surgeon who consults with you is the same person who will carry out the procedure","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Check that the surgeon you consult with, will be the same person carrying out the procedure.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C5","text":"Expect two consultations with the treating surgeon before any surgery, which also gives you time to reconsider","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/conditions/cosmetic-procedures/cosmetic-surgery-abroad/","host":"nhs.uk","quote":"You should have 2 consultations with the surgeon treating you before any surgery.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"Pressure to decide quickly, or cheap time-limited offers to book now","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Don’t be pressured into quick decisions either through forceful persuasion or cheap, time limited offers.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"F2","text":"The doctor you consult may not be the one who actually treats you","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Check that the surgeon you consult with, will be the same person carrying out the procedure.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"F3","text":"Adverts or information promising complete success for the treatment","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Any advert or information that guarantees complete success should raise concerns.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"warning_signs":{"status":"ok","items":[{"id":"W1","text":"Unusual bleeding or bruising during targeted therapy","urgency":"contact_clinic","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/side-effects/bleeding-bruising","host":"cancer.gov","quote":"Some cancer treatments, such as chemotherapy and targeted therapy, can increase your risk of bleeding and bruising.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W2","text":"Diarrhea that lasts or becomes more severe","urgency":"contact_clinic","general":false,"source":{"url":"https://cancer.gov/about-cancer/treatment/side-effects/diarrhea","host":"cancer.gov","quote":"Ask the health care team about when you should call them if the diarrhea lasts or becomes more severe.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W3","text":"Fever higher than your care team expects","urgency":"contact_clinic","general":true,"source":{"url":"https://mdanderson.org/patients-family/diagnosis-treatment/emotional-physical-effects/targeted-therapy-side-effects.html","host":"mdanderson.org","quote":"A fever higher than what your care team told you to expect","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"take_home":{"status":"ok","items":[{"id":"T1","text":"Shows which follow-up tests are due and which doctors are responsible for care","document":"written aftercare plan","source":{"url":"https://www.cdc.gov/cancer/survivors/life-after-cancer/survivorship-care-plans.htm","host":"cdc.gov","quote":"Your plan should say when you need to get follow-up tests, and which doctors are responsible for your care.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":403}},{"id":"T2","text":"Gives the home doctor an up-to-date, clear picture of the treatment received","document":"end of treatment summary","source":{"url":"https://cht.nhs.uk/services/clinical-services/oncology/end-of-treatment-summary","host":"cht.nhs.uk","quote":"It also provides the GP with an up-to-date and clear understanding of the patient's treatment.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"T3","text":"Ask for copies of all prescriptions before you leave","document":"prescription copies","source":{"url":"https://travelhealthpro.org.uk/news/699/travelling-abroad-for-treatment","host":"travelhealthpro.org.uk","quote":"Remember to ask for copies of all your treatment records, including prescriptions, scans and x-rays before you leave.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"alternatives":{"status":"ok","items":[{"id":"A1","text":"You want a treatment that may slow or stop cancer growth","name":"Chemotherapy","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/chemotherapy","host":"cancer.gov","quote":"Chemotherapy can be used to cure cancer, lessen the chance it will return, or stop or slow its growth.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200},"operation_id":37},{"id":"A2","text":"You want treatment that helps your immune system fight the cancer","name":"Immunotherapy","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"Immunotherapy is a type of cancer treatment that helps your immune system fight cancer.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200},"operation_id":283}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"technique_details":{"status":"ok","items":[{"id":"small-molecule-inhibitors","name":"Small-molecule inhibitors (oral, e.g. tyrosine kinase inhibitors)","how_it_works":{"text":"Small drugs enter cells and act on targets inside them","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies/targeted-therapies-fact-sheet","host":"cancer.gov","quote":"Small-molecule drugs are small enough to enter cells easily, so they are used for targets that are inside cells.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}},{"id":"monoclonal-antibodies","name":"Monoclonal antibodies (intravenous or subcutaneous)","how_it_works":{"text":"Antibodies attach to specific targets found on cancer cells","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies/targeted-therapies-fact-sheet","host":"cancer.gov","quote":"These proteins are designed to attach to specific targets found on cancer cells.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}},{"id":"antibody-drug-conjugates","name":"Antibody-drug conjugates","how_it_works":{"text":"Antibodies are linked to cell-killing substances that reach cancer cells","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies/targeted-therapies-fact-sheet","host":"cancer.gov","quote":"Some monoclonal antibodies are combined with cell-killing substances such as toxins, chemotherapy drugs, or radiation.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"preop_tests":{"status":"ok","items":[{"id":"T1","name":"Blood tests","aliases":["Blood tests","Blood test","Blood test results","Blood testing"],"kind":"lab","origin":[{"field":"preparation","text":"Molecular target or biomarker confirmed by tissue or blood testing"},{"field":"preparation","text":"Baseline blood tests and organ function assessment"},{"field":"initial_assessment_documents","text":"Recent blood test results"},{"field":"packages","text":"Blood tests"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T2","name":"Genomic testing","aliases":["Genomic testing","Molecular or genomic testing","Molecular testing"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"Molecular or genomic testing report"}],"what_it_checks":{"text":"Helps doctors tailor the targeted treatment to the individual patient","source":{"url":"https://www.ncbi.nlm.nih.gov/sites/books/n/nap21860/ch1/","host":"ncbi.nlm.nih.gov","quote":"Such predictive biomarker tests are used by health care providers to tailor treatment to an individual patient's clinical condition and treatment goals.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T3","name":"CT scan","aliases":["CT scan","CT","CT scans","Computed tomography"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Recent CT or PET-CT scans"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T4","name":"PET-CT scan","aliases":["PET-CT scan","PET-CT","PET-CT scans","PET CT"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Recent CT or PET-CT scans"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T5","name":"Blood biochemistry test","aliases":["Blood biochemistry test","Biochemistry blood test"],"kind":"lab","origin":[{"field":"packages","text":"Biochemistry blood test"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null}],"checked_at":"2026-11-16","next_check_at":"2027-11-16","version":1},"prep_in_advance":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-16","next_check_at":"2027-02-14"},"visit_and_day":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-16","next_check_at":"2027-02-14"},"if_something_changes":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-16","next_check_at":"2027-02-14"}}},"techniques":[{"id":"small-molecule-inhibitors","name":"Small-molecule inhibitors (oral, e.g. tyrosine kinase inhibitors)","how_it_works":{"id":"H1","text":"Small drugs enter cells and act on targets inside them","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies/targeted-therapies-fact-sheet","host":"cancer.gov","quote":"Small-molecule drugs are small enough to enter cells easily, so they are used for targets that are inside cells.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Patients whose tumor carries a matching targetable alteration","price_from":6500,"recovery":"No recovery period; usually taken continuously at home with periodic monitoring."},{"id":"monoclonal-antibodies","name":"Monoclonal antibodies (intravenous or subcutaneous)","how_it_works":{"id":"H1","text":"Antibodies attach to specific targets found on cancer cells","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies/targeted-therapies-fact-sheet","host":"cancer.gov","quote":"These proteins are designed to attach to specific targets found on cancer cells.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Patients with target-expressing tumors such as HER2-positive cancers","price_from":8000,"recovery":"Given at scheduled infusion visits; usually no recovery time beyond infusion-related effects."},{"id":"antibody-drug-conjugates","name":"Antibody-drug conjugates","how_it_works":{"id":"H1","text":"Antibodies are linked to cell-killing substances that reach cancer cells","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies/targeted-therapies-fact-sheet","host":"cancer.gov","quote":"Some monoclonal antibodies are combined with cell-killing substances such as toxins, chemotherapy drugs, or radiation.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Selected patients with target-expressing cancers and suitable prior treatment history","price_from":11000,"recovery":"Given at scheduled infusion visits with monitoring for agent-specific toxicity."}],"alternatives":{"status":"ok","items":[{"id":"A1","text":"You want a treatment that may slow or stop cancer growth","name":"Chemotherapy","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/chemotherapy","host":"cancer.gov","quote":"Chemotherapy can be used to cure cancer, lessen the chance it will return, or stop or slow its growth.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200},"operation_id":37},{"id":"A2","text":"You want treatment that helps your immune system fight the cancer","name":"Immunotherapy","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"Immunotherapy is a type of cancer treatment that helps your immune system fight cancer.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200},"operation_id":283}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"diagnostic":{"status":"not_applicable"},"country":{"why":{"status":"ok","items":[{"id":"Y1","text":"Republic of Korea runs a medical call center where consultants advise overseas patients in several languages around the clock","specialties":[],"source":{"url":"https://www.khidi.or.kr/board?menuId=MENU00807","host":"khidi.or.kr","quote":"Professional consultants provide advices in Korean, English, Japanese, Chinese, Russian and Arabic 24 hours daily.","tier":"government","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-11","next_check_at":"2027-05-10","version":1},"travel":{"status":"ok","items":[{"id":"V1","item":"visa","audience":"uk","volatile":true,"text":"UK travelers can enter Republic of Korea for up to 90 days for short-term business or tourism","source":{"url":"https://www.gov.uk/foreign-travel-advice/south-korea/entry-requirements","host":"gov.uk","quote":"You can enter South Korea for up to 90 days for short-term business or tourism.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V2","item":"visa","audience":"us","volatile":true,"text":"US passport holders need a visa for stays in Republic of Korea longer than 90 days and for purposes other than tourism or business, including employment","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/SouthKorea.html","host":"travel.state.gov","quote":"Visa required for all other purposes, including employment, teaching English, and for stays longer than 90 days.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V3","item":"passport_validity","audience":"uk","volatile":true,"text":"For a tourist stay of up to 90 days in Republic of Korea, the passport must expire after the date you leave","source":{"url":"https://www.gov.uk/foreign-travel-advice/south-korea/entry-requirements","host":"gov.uk","quote":"To enter South Korea as a tourist for up to 90 days, your passport must have an ‘expiry date’ after the date you are leaving South Korea.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V4","item":"passport_validity","audience":"us","volatile":true,"text":"A valid U.S. passport is required to enter Republic of Korea","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/SouthKorea.html","host":"travel.state.gov","quote":"You must have a valid U.S. passport to enter Korea.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V5","item":"medicines","audience":"all","volatile":false,"text":"Republic of Korea customs allow small amounts of medication for personal use, if kept in carry-on baggage","source":{"url":"https://www.gov.uk/foreign-travel-advice/south-korea/health","host":"gov.uk","quote":"South Korean customs authorities allow you to bring small amounts of medication for your personal use, if it is kept in carry-on baggage.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V6","item":"hospital_payment","audience":"all","volatile":false,"text":"In Republic of Korea, health care providers usually require payment before treatment or will not release a patient until hospital bills are paid","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/SouthKorea.html","host":"travel.state.gov","quote":"In most cases, health care providers will require payment in advance of treatment or will not release a patient until hospital bills are paid.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V7","item":"emergency_number","audience":"all","volatile":false,"text":"In Republic of Korea, call 119 and ask for an ambulance","source":{"url":"https://www.gov.uk/foreign-travel-advice/south-korea/health","host":"gov.uk","quote":"Call 119 and ask for an ambulance.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-11","next_check_at":"2026-12-11","version":1},"other_countries_with_page":["austria","azerbaijan","china","egypt","germany","india","israel","italy","latvia","malaysia","poland","spain","switzerland","thailand","turkey","ukraine","united-states"]},"often_combined_with":{"status":"missing","reason":"not_collected"},"reviews":{"avg_rating":4.6,"count":90,"scope":"clinic","rating_scale":5,"pros":{"status":"missing","reason":"not_collected"},"cons":{"status":"missing","reason":"not_collected"}},"current":{"seo_text":"<p>Targeted therapy in the Republic of Korea typically costs from _op_284_price_from_ to _op_284_price_to_. Final expenses depend on the drug type, mutation profile, and the specific hospital tier. In the US, patients pay _price_compare_US_average_ on average for similar oncology treatments. Patients choosing South Korea can save approximately _price_percent_discount_%. These costs usually cover the medication, expert consultations, and essential diagnostic monitoring.</p>\n\n<ul>\n<li><strong>Lutetium-177 therapy:</strong> _op_830_price_from_ to _op_830_price_to_ for targeted radioligand treatment.</li>\n<li><strong>Standard drug cycles:</strong> Standard protocols at major university hospitals often range from $10,500 to $18,900.</li>\n<li><strong>Advanced clinical protocols:</strong> Specialized digital hospitals may charge 20-40% more for complex, data-driven therapies.</li>\n<li><strong>Regional price differences:</strong> Facilities in Incheon often provide more competitive rates than clinics in central Seoul.</li>\n</ul>\n\n<p><strong>Bookimed Expert Insight:</strong> Choosing a facility like Seoul National University Bundang Hospital (SNUBH) offers unique value through its status as the first fully digital hospital in Korea. This digital integration helps reduce medical errors. For those seeking presidential-level care, Samsung Medical Center and Seoul National University Hospital (SNUH) are the gold standard. These centers are frequently credited by Newsweek as World's Best Hospitals. Many top-tier Korean centers like Severance Hospital and Korea University Anam Hospital hold Joint Commission International (JCI) accreditation, ensuring Western safety standards at significant savings.</p>","faq":[{"q":"Is targeted therapy available for all types of cancer in South Korea?","a":"<p>South Korea offers extensive targeted therapy for common cancers like lung, breast, and colorectal but does not cover every type. Availability depends on specific genetic mutations identified through NGS testing. Major institutions like Samsung Medical Center and Severance Hospital provide advanced drugs for cases with approved biomarkers.</p> <ul> <li><strong>Available cancers:</strong> Targeted drugs treat lung, breast, colorectal, and specific blood cancers.</li> <li><strong>Genetic testing:</strong> Routine Next-Generation Sequencing (NGS) panels identify eligible mutations for matched therapies.</li> <li><strong>Lung cancer:</strong> EGFR inhibitors like osimertinib are widely accessible for qualified patients.</li> <li><strong>Clinic credentials:</strong> Top centers hold JCI and Korea Institute for Healthcare Accreditation (KOIHA) certifications.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While targeted therapy costs start at _op_284_price_from_, real-world value comes from South Korea’s rapid drug approval cycle. Samsung Medical Center and Seoul National University Hospital often provide access to new therapies years before other regions. This makes Korea a strategic choice for patients seeking the latest FDA-approved molecules that are not yet regional standards.</p> <p><strong>Patient Consensus:</strong> Patients emphasize getting NGS biomarker testing early at major hospitals to unlock treatment options. Many travelers note that while drugs for common mutations are accessible, off-label treatments for rare cases remain expensive without local insurance.</p>"},{"q":"Which hospitals in South Korea specialize in targeted therapy and what distinguishes them?","a":"<p>South Korea's top hospitals for targeted therapy include Samsung Medical Center, Severance Hospital, and Seoul National University Hospital. These institutions distinguish themselves through high-volume genomic analysis, Next-Generation Sequencing, and multidisciplinary teams that match specific genetic mutations to precise drug regimens for complex cancers.</p> <ul> <li><strong>Samsung Medical Center:</strong> Features a Precision Oncology Center with over 10,000 genomic analysis cases.</li> <li><strong>Severance Hospital:</strong> Offers 24/7 oncology ICU support and rapid access to advanced immunotherapies.</li> <li><strong>Seoul National University:</strong> Fully digitalized facility achieving some of the nation's highest cancer success rates.</li> <li><strong>Ewha Womans University:</strong> Specializes in precision oncology for breast and gynecological cancers with aesthetic focus.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Samsung Medical Center and Seoul National University Hospital serve a combined 3.6 million patients annually. This massive volume allows their specialists to encounter rare genetic mutations more frequently than most Western centers. This deep data pool directly improves the accuracy of their Next-Generation Sequencing panels for therapy matching.</p> <p><strong>Patient Consensus:</strong> Patients value the speed of genomic mapping, which often takes only days. Many suggest requesting Next-Generation Sequencing upfront to ensure the most effective therapy match immediately.</p>"},{"q":"Does South Korean National Health Insurance (NHI) cover targeted therapy?","a":"<p>South Korean National Health Insurance (NHI) covers many targeted therapies, typically reducing patient costs to 5% of the total medical bill for reimbursed treatments. Coverage depends on specific drug approval for the patient's cancer type and stage as determined by the Health Insurance Review and Assessment Service (HIRA).</p> <ul> <li><strong>Co-payment rates:</strong> Patients generally pay 5% for reimbursed cancer drugs under the special benefit program.</li> <li><strong>Reimbursement list:</strong> Approximately 150 targeted agents are currently covered for specific, approved medical indications.</li> <li><strong>Non-reimbursed costs:</strong> Patients must pay 100% out-of-pocket if a therapy is used off-label or non-listed.</li> <li><strong>Approval timeline:</strong> Authorization for specific targeted treatments usually takes between 2 to 4 weeks.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While NHI offers significant savings, university hospitals like Severance Hospital or Samsung Medical Center often have higher approval odds for complex cases. These top-tier facilities participate in international clinical trials, providing access to cutting-edge therapies before they reach the official reimbursement list.</p> <p><strong>Patient Consensus:</strong> Patients report that while coverage is generous compared to US costs, the bureaucracy can cause delays. Many recommend bringing detailed genetic reports to speed up the authorization process at major Seoul hospitals.</p>"},{"q":"How does South Korea speed up patient access to new targeted drugs?","a":"<p>South Korea accelerates access to targeted drugs through the GIFT (Global Innovative Products on Fast Track) system and the 2025 approval reforms. These pathways prioritize severe or rare diseases. They aim to reduce regulatory review timelines from 420 days to approximately 295 days.</p> <ul> <li><strong>Regulatory speed:</strong> Accelerated pathways like GIFT target drug approval within 90 days for critical illnesses.</li> <li><strong>Parallel processing:</strong> Companies can apply for reimbursement and marketing authorization simultaneously to reduce wait times.</li> <li><strong>Affordability exemptions:</strong> Drugs for life-threatening diseases may bypass economic evaluations if reimbursed in A7 countries.</li> <li><strong>Conditional approval:</strong> The ministry grants marketing rights based on phase 2 data for oncology treatments.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Samsung Medical Center and Severance Hospital often provide the fastest access through named patient programs. These programs allow patients to receive new drugs 3–6 months before official reimbursement. In some cases, these medications are available at 20–50% of the standard US price.</p> <p><strong>Patient Consensus:</strong> Patients report that the prior approval system through major Seoul hospitals can secure insurance coverage for advanced lung cancer drugs like Tagrisso within just a few days.</p>"},{"q":"What regulatory framework governs targeted therapy in the Republic of Korea?","a":"<p>The Ministry of Food and Drug Safety (MFDS) supervises targeted therapy in the Republic of Korea under the Pharmaceutical Affairs Act. This framework distinguishes between small-molecule drugs and advanced biological products. Specialized systems like the GIFT program and ARMAB Act accelerate access to innovative cancer treatments.</p> <ul> <li><strong>Core legislation:</strong> The Pharmaceutical Affairs Act regulates manufacturing, distribution, and standard drug approvals.</li> <li><strong>Advanced biologics:</strong> The ARMAB Act provides specialized safety frameworks for cell and gene therapies.</li> <li><strong>Fast-track approval:</strong> The GIFT program shortens approval timelines by 25% for life-threatening diseases.</li> <li><strong>Market access:</strong> Risk Sharing Agreements (RSA) manage clinical uncertainty between developers and insurance authorities.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Clinical data from top-tier institutions like Samsung Medical Center and Seoul National University Hospital shows a unique regulatory advantage. These major academic centers often navigate the MFDS approval process for targeted therapies 6 to 12 months faster than the FDA. This speed allows patients to access newer Japanese or European therapies before they reach the US market.</p> <p><strong>Patient Consensus:</strong> Patients emphasize that MFDS approval does not guarantee insurance coverage. Many coordinate with hospital networks to manage out-of-pocket costs for non-reimbursed agents through pharmaceutical assistance programs.</p>"}],"h2":[{"text":"Какая цена таргетной терапии в Южной Корее?","kind":"content"},{"text":"Преимущества и гарантии Bookimed","kind":"content"},{"text":"Ваш личный врач-координатор Bookimed","kind":"content"},{"text":"Лучшие клиники по таргетной терапии в Южной Корее — 8 проверенных вариантов с ценами","kind":"content"},{"text":"Обзор процедуры Таргетная терапия в Южной Корее","kind":"content"},{"text":"Получите медицинскую консультацию по таргетной терапии в Южной Корее: Выбирайте среди лучших специалистов в этой области","kind":"content"},{"text":"Видеоистории пациентов Bookimed","kind":"content"},{"text":"Отзывы о Bookimed: узнайте о реальном опыте пациентов","kind":"content"},{"text":"Поделитесь этим материалом","kind":"content"},{"text":"FAQ по таргетной терапии в Южной Корее","kind":"content"},{"text":"Получить бесплатную консультацию","kind":"content"}]},"placeholders":{"price_from":"{{price_from}}","clinics_count":"{{clinics_count}}","cities_count":"{{cities_count}}","savings_pct":"{{savings_pct}}","data_date":"{{data_date}}"},"legal":{"restricted_markets":{"status":"missing","reason":"not_collected"}},"conflicts":[]}